Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/OCF ratio is N/A as of 2026-10-06T14:16:36.476Z.
Calculation as of: 2026-10-06T14:16:36.476Z.
Quote observation: 2026-10-06T14:14:24.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 2d15fccd73dd71321fa30efb235d10704747171fee005d1a5dd6499fafc6c703
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/OCF RATIO
N/A
Estrella Immunopharma, Inc.
Market Cap
$18.87M
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.86M
Price/OCF Ratio
N/A
TTM Avg
43.53
3Y Avg
44.24
5Y Avg
48.21
| NAME | MARKET CAP | PRICE/OCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Estrella Immunopharma, Inc. (ESLA) | $18.87M | N/A | N/A | N/A | N/A |
| Cosmos Health Inc. (COSM)vs › | $19.13M | N/A | 14.35 | 40.20 | 40.20 |
| Actuate Therapeutics Inc (ACTU)vs › | $19.16M | N/A | N/A | N/A | N/A |
| Modular Medical, Inc. (MODD)vs › | $19.56M | N/A | N/A | N/A | N/A |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.67M | N/A | N/A | N/A | N/A |
| Lipocine Inc. (LPCN)vs › | $17.39M | N/A | N/A | N/A | N/A |
| Dyadic International, Inc. (DYAI)vs › | $16.86M | N/A | 43.53 | 44.24 | 48.21 |
| Bionano Genomics, Inc. (BNGO)vs › | $16.75M | N/A | N/A | N/A | N/A |
| BioCardia, Inc. (BCDA)vs › | $16.22M | N/A | 64.40 | 51.01 | 44.81 |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.80M | N/A | N/A | N/A | N/A |
P/OCF Ratio
N/A
P/FCF Ratio
N/A
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
